A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Prostate cancer is one of the most common cancers among men in the U.S. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society. But experts ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

DENVER (KDVR) — Prostate cancer is the second most common cancer among U.S. men, behind only lung cancer, according to the American Cancer Society. An estimated 300,000 men will be diagnosed with ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...